Pittsburgh, PA – According to filings with the U.S. Securities and Exchange Commission, Knopp Biosciences is raising $26,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Michael Bozik played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Knopp Biosciences

Knopp Biosciences seeks to discover, develop, and deliver breakthrough medicines for urgent unmet medical needs. Our goal is to accelerate and advance treatment, change the course of devastating diseases, and improve the lives of patients and their families.

To learn more about Knopp Biosciences, visit http://knoppbio.com/

Contact:
Michael Bozik, Chief Executive Officer
412-488-1776
michael.bozik@knoppbio.com
https://www.linkedin.com/in/michael-bozik-6691525/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved